CNP Tablet (Camostat Mesilate)

Adult dose

○ Chronic pancreatitis Adults: Administer 200mg of camostat mesilate per dose orally 3 times daily. ○ Reflux esophagitis after gastrectomy Adults: Administer 100mg of this medicine per dose 3 times daily. Adjust the dose as appropriate according to symptoms.

This medication should not be used for patients in severe conditions requiring meal restrictions, such as gastric suction, fasting, or dysphagia. The effectiveness of this medication is not expected in patients with gastroesophageal reflux disease caused by postoperative gastric reflux. Additionally, this medication contains lactose, so it should not be administered to patients with genetic disorders that prevent the breakdown of lactose. Caution should be exercised while using this medication in pregnant women or women who may become pregnant, children, and elderly patients. While using this medication, if an increase in eosinophils is observed in blood tests or if there is a rare decrease in white blood cells and platelets, the dosage should be reduced or the medication should be discontinued if such symptoms appear. Allergic reactions such as skin rash or itching may occasionally occur, and the medication should be stopped if such symptoms appear. Gastrointestinal side effects may include loss of appetite, nausea, dry mouth, abdominal pain, abdominal discomfort, abdominal distension, diarrhea, rare vomiting, heartburn, and constipation. There may be an increase in liver function test values or liver dysfunction, so caution is necessary. Renal function-related test values may rarely increase. Edema may occur, and rarely, there may be a decrease in blood sugar or an increase in blood potassium levels. If symptoms do not improve, it is advisable not to use this medication for a prolonged period. During pregnancy, high-dose administration has been reported to cause fetal weight reduction in animal experiments, so pregnant women should avoid high-dose administration. The safety for children or newborns has not been confirmed due to lack of usage experience. Elderly patients may experience more severe adverse reactions than adults, so caution is necessary. When using this medication with Olmesartan Medoxomil products, discoloration may occur, so it is advisable to dispense them in separate pill containers.

• Eosinophilia
• leukopenia
• thrombocytopenia
• rash
• itching
• loss of appetite
• nausea
• dry mouth
• abdominal pain
• abdominal discomfort

This medication should be stored in a sealed container to prevent air ingress and kept at room temperature between 1 to 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a long time.

Appearance

White to yellowish round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle